$LGND LIGAND PHARMACEUTICALS INC Insider Trading Week 32/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LIGAND PHARMACEUTICALS INC in week 32/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 850 | 8,475 | 43,085 | |
| Aug 10 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 6,100 | 60,817 | 43,935 | |
| Aug 10 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 850 | 8,475 | 95,770 | 94.9 K to 95.8 K (+0.90 %) |
| Aug 10 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 127.51 | 6,100 | 777,824 | 94,920 | 101 K to 94.9 K (-6.04 %) |
| Aug 10 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 6,100 | 60,817 | 101,020 | 94.9 K to 101 K (+6.43 %) |
| Aug 10 2017 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 126.96 | 18,625 | 2,364,671 | 24,423 | 43 K to 24.4 K (-43.27 %) |
| Aug 10 2017 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Option Exercise | M | 21.00 | 5,483 | 115,143 | 5,000 | |
| Aug 10 2017 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Sell | S | 125.00 | 5,483 | 685,375 | 139,171 | 144.7 K to 139.2 K (-3.79 %) |
| Aug 10 2017 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Buy | M | 21.00 | 5,483 | 115,143 | 144,654 | 139.2 K to 144.7 K (+3.94 %) |
| Aug 08 2017 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | VP, Finance and CFO | Payment of Exercise | F | 122.06 | 609 | 74,335 | 14,706 | 15.3 K to 14.7 K (-3.98 %) |